Fungal meningitis.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 2277199)

Published in Infect Dis Clin North Am on December 01, 1990

Authors

C B Treseler1, A M Sugar

Author Affiliations

1: Section of Infectious Diseases, Evans Memorial Department of Clinical Research, Boston University Medical Center, Massachusetts.

Articles by these authors

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med (1992) 5.84

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med (1992) 3.65

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60

Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. Am J Med (1989) 2.20

Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 2.15

Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis (1995) 2.11

Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene. Infect Immun (1998) 1.76

Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med (1993) 1.46

Paracoccidioidomycosis and AIDS: an overview. Clin Infect Dis (1995) 1.43

Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice. Antimicrob Agents Chemother (1986) 1.42

Clinical research. Science (2000) 1.39

Fungal infections in the immunocompromised host. Diagn Microbiol Infect Dis (1990) 1.32

Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. Am J Med (1983) 1.26

Rapid diagnosis of nocardiosis with an enzyme immunoassay. J Infect Dis (1987) 1.20

Antibody response in human nocardiosis: identification of two immunodominant culture-filtrate antigens derived from Nocardia asteroides. J Infect Dis (1985) 1.19

Identification of a common immunodominant protein in culture filtrates of three Nocardia species and use in etiologic diagnosis of mycetoma. J Clin Microbiol (1987) 1.12

Cloning and nucleotide sequence of a specific DNA fragment from Paracoccidioides brasiliensis. J Clin Microbiol (1995) 1.11

Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia? J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.10

Treatment of murine pulmonary mucormycosis with SCH 42427, a broad-spectrum triazole antifungal drug. J Antimicrob Chemother (1994) 1.08

Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis (1984) 1.08

Capnocytophaga septicemia. N Engl J Med (1980) 1.07

Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature. Cancer (1985) 1.04

What's the price of a research subject? N Engl J Med (1999) 0.99

Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and blastomyces dermatitidis in vitro. J Leukoc Biol (1984) 0.98

Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometry. Antimicrob Agents Chemother (1979) 0.96

Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. Am Rev Respir Dis (1983) 0.95

Bacillus licheniformis sepsis. JAMA (1977) 0.95

Susceptibility of Blastomyces dermatitidis strains to products of oxidative metabolism. Infect Immun (1983) 0.95

Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity. Infect Immun (1985) 0.94

Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazole. J Med Vet Mycol (1996) 0.94

Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils. J Antimicrob Chemother (1989) 0.92

New rapid assay for nafcillin in serum by spectrofluorometry. Antimicrob Agents Chemother (1979) 0.90

Short report: use of the polymerase chain reaction to detect Paracoccidioides brasiliensis in murine paracoccidioidomycosis. Am J Trop Med Hyg (1998) 0.89

Ketoconazole treatment of coccidioidal meningitis. Ann N Y Acad Sci (1988) 0.89

Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement. Infect Immun (1983) 0.88

Herpes zoster ophthalmicus and granulomatous angiitis. An ill-appreciated cause of stroke. J Am Geriatr Soc (1986) 0.86

The iron-hydrogen peroxide-iodide system is fungicidal: activity against the yeast phase of Blastomyces dermatitidis. J Leukoc Biol (1984) 0.86

Nocardia in naturally acquired and experimental infections in animals. J Hyg (Lond) (1983) 0.86

Fluconazole in transplant recipients: options and limitations. Transpl Infect Dis (2000) 0.85

Synthesis of heat-shock proteins in mycelia and yeast forms of Paracoccidioides brasiliensis. J Med Microbiol (1994) 0.85

In vitro activity of LY121019 against Candida species and Torulopsis glabrata. Eur J Clin Microbiol Infect Dis (1988) 0.85

Candida esophagitis. Adv Intern Med (1991) 0.85

Fungicidal activity of murine broncho-alveolar macrophages against Blastomyces dermatitidis. J Med Microbiol (1986) 0.84

Making antifungal susceptibility testing a clinically useful tool. Clin Infect Dis (1997) 0.82

Possible thiabendazole-induced theophylline toxicity. Am Rev Respir Dis (1980) 0.81

Aspergillus meningitis in an immunocompetent adult successfully treated with itraconazole. Clin Infect Dis (1996) 0.80

Combined treatment: antifungal drugs with antibodies, cytokines or drugs. Med Mycol (2000) 0.80

Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia. Arch Intern Med (1985) 0.79

Interaction of fluconazole and cyclosporine. Ann Intern Med (1989) 0.79

Characteristics of the pulmonary cellular immune response to two strains of Blastomyces dermatitidis in the mouse. Am Rev Respir Dis (1985) 0.79

A cephalosporin active in vivo against Nocardia: efficacy of cefotaxime in murine model of acute pulmonary nocardiosis. J Hyg (Lond) (1983) 0.78

Pneumocystis carinii pneumonia associated with solid ectopic corticotropin-producing tumors. Arch Neurol (1992) 0.78

Effect of various common beverages on the dissolution of ketoconazole tablets. AIDS (1992) 0.77

Gonococcal endocarditis in a patient with mitral valve prolapse: study of host immunology and organism characteristics. Am J Med Sci (1982) 0.77

Toxic effect of products of oxidative metabolism on the yeast form of Paracoccidioides brasiliensis. J Med Microbiol (1984) 0.77

Pneumocystis carinii pneumonia complicating somatostatin therapy of Cushing's syndrome in a patient with metastatic pancreatic islet cell carcinoma and Zollinger-Ellison syndrome. Am J Gastroenterol (1991) 0.75

P&T Committee review of fluconazole: an effective alternative to antifungal therapy. Hosp Formul (1990) 0.75

Reduced amphotericin toxicity in an albumin vehicle. J Drug Target (1993) 0.75

Case 49-1988: Histoplasma capsulatum or Blastomyces dermatitidis? N Engl J Med (1989) 0.75

Ketoconazole effects. Ann Intern Med (1982) 0.75